Does Rallies show 13F holders for AGL?

Yes. Rallies tracks hedge fund and 13F ownership data for AGL, including fund names, share counts, latest tracked quarter, and position changes when available.

Is AGL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AGL. It does not provide personalized investment advice.

AGL (agilon health, inc.) Stock Analysis - Hedge Fund Holdings

agilon health, inc. (AGL) is a publicly traded Healthcare sector company. As of May 21, 2026, AGL trades at $80.01 with a market cap of $1.45B and a P/E ratio of 0.00. AGL moved -8.59% today. Year to date, AGL is +367.52%; over the trailing twelve months it is +30.55%. Its 52-week range spans $7.48 to $152.00. Analyst consensus is neutral with an average price target of $37.46. Rallies surfaces AGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AGL stock?

Hedge funds tracked by Rallies that own AGL include Centerbook Partners, Eisler Capital, and Bridgewater Associates. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for agilon health, inc..

AGL Key Metrics

Key financial metrics for AGL
Metric	Value
Price	$80.01
Market Cap	$1.45B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.11%
52-Week High	$152.00
52-Week Low	$7.48
Volume	28
Avg Volume	0
Revenue (TTM)	$5.82B
Net Income	$-354.54M
Gross Margin	0.00%

Top Hedge Funds Holding AGL

Centerbook Partners holds 7.02M shares of AGL, changed -38.56% as of Dec 31, 2025.
Eisler Capital holds 193.53K shares of AGL, changed +0.00% as of Jun 30, 2024.
Bridgewater Associates holds 24.54K shares of AGL, changed -79.08% as of Dec 31, 2024.

Latest AGL News

Agilon Health Shares Surge 117.76% to $60.65 on Upgraded 2026 Guidance — May 7, 2026
Agilon Health Q1 EPS Beats Estimates, Raises Full-Year Revenue Guidance to $5.68–5.81B — May 6, 2026
AGL Energy Cuts Battery Project Costs by 50% on New South Wales Builds — Apr 20, 2026
agilon health to Implement 1-for-25 Reverse Split on March 30 — Mar 18, 2026
Agilon Health Shares Soar 23% on CMO’s $301K Stock Buy — Mar 4, 2026

Recent AGL Insider Trades

Shaker Benjamin bought 500.00K (~$301.05K) on Mar 2, 2026.
Wulf John William bought 81.00K (~$50.94K) on Nov 12, 2025.
McLoughlin Karen bought 25.00K (~$55.08K) on Dec 13, 2024.

AGL Analyst Consensus

15 analysts cover AGL: 0 strong buy, 4 buy, 8 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $37.46.

Common questions about AGL

Who owns AGL stock?: Hedge funds tracked by Rallies that own AGL include Centerbook Partners, Eisler Capital, and Bridgewater Associates. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for agilon health, inc..
Does Rallies show 13F holders for AGL?: Yes. Rallies tracks hedge fund and 13F ownership data for AGL, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AGL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AGL. It does not provide personalized investment advice.